Financial Performance - Revenue for Q3 2025 was CNY 225,479,083.99, a decrease of 39.25% year-over-year[3] - Net profit attributable to shareholders was a loss of CNY 27,367,028.14, representing a decline of 4,004.28% compared to the previous year[3] - Total operating revenue decreased to ¥753,521,493.62 from ¥1,002,639,030.84, representing a decline of approximately 25% year-over-year[26] - Net profit for the period was a loss of ¥34,660,651.14, compared to a profit of ¥18,594,238.75 in the previous year, indicating a significant downturn[26] - The company reported a basic and diluted earnings per share of -0.0416, compared to 0.0174 in the previous year[26] - Other comprehensive income after tax was a loss of ¥7,319,782.48, compared to a loss of ¥2,006,874.66 in the previous year[26] Cash Flow - The net cash flow from operating activities for the year-to-date was CNY 118,748,643.28, down 39.45%[3] - Operating cash inflow for the current period was CNY 1,020,973,090.17, an increase of 3.1% from CNY 991,061,052.34 in the previous period[28] - Net cash flow from operating activities decreased to CNY 118,748,643.28, down 39.5% from CNY 196,120,008.08 in the previous period[28] - Cash inflow from investment activities increased significantly to CNY 1,367,022,431.23, compared to CNY 941,607,273.54 in the previous period, marking a 45.0% increase[28] - Net cash flow from investment activities turned positive at CNY 76,639,819.87, recovering from a negative CNY 177,596,656.86 in the previous period[28] - Cash outflow from financing activities rose to CNY 362,077,777.17, compared to CNY 92,347,160.41 in the previous period, indicating a significant increase in financing costs[28] - Net cash flow from financing activities worsened to -CNY 312,877,777.17, compared to -CNY 55,308,201.13 in the previous period[28] - The ending cash and cash equivalents balance decreased to CNY 333,656,397.54 from CNY 373,073,067.74 in the previous period[28] - The company received CNY 20,000,000.00 in new borrowings during the current period, indicating ongoing financing efforts[28] - The company reported a cash inflow of CNY 49,200,000.00 from financing activities, up from CNY 37,038,959.28 in the previous period[28] - The company’s cash flow from operating activities was impacted by increased payments for goods and services, totaling CNY 580,433,233.76, up from CNY 494,263,080.56 in the previous period[28] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,560,184,899.49, an 8.19% decrease from the end of the previous year[3] - The company's total assets decreased to ¥3,560,184,899.49 from ¥3,877,889,089.89, a decline of approximately 8%[24] - Current assets totaled ¥1,617,974,834.22, down from ¥1,892,877,927.21, reflecting a decrease of about 14%[24] - Total liabilities decreased to ¥829,974,414.04 from ¥1,102,046,421.18, a reduction of approximately 25%[24] - The company's cash and cash equivalents decreased to ¥397,510,051.11 from ¥504,208,728.08, a decline of about 21%[24] Shareholder Information - The total number of common shareholders at the end of the reporting period is 65,472[8] - The largest shareholder, Liang Guiqiu, holds 29.52% of the shares, amounting to 249,586,723 shares[8] - The company has a total of 62,396,681 unrestricted shares held by Liang Guiqiu[8] - The company has not disclosed any changes in the shareholding structure of the top 10 shareholders due to margin trading activities[8] Investments and Projects - The company reported a significant increase in investment income of CNY 8,728,405.81, up 591.16% due to higher returns from financial products[6] - The net cash flow from investing activities increased by 143.15% to CNY 254,236,476.73, primarily from the maturity of bank wealth management products[6] - The company experienced a 465.70% decrease in net cash flow from financing activities, totaling -CNY 257,569,576.04, due to repayments of convertible bonds[6] - The company has significant ongoing projects, including a contract with Henan Ningling County People's Hospital valued at 150 million RMB, which has been completed[10] - Another major project is with Shaanxi Chengcheng County Hospital, valued at 600 million RMB, currently in the engineering settlement phase[10] - The company has completed the construction of the new hospital project in Heshan City, with the project now in the settlement phase[10] - The company is currently engaged in a project in Fuan City, valued at approximately 239.95 million RMB, which is still under construction[10] Legal Matters - The company is involved in an arbitration case with Xuchang Second People's Hospital, with a claim amounting to 293.18 million RMB[11] - The company also has a separate arbitration case involving a loan dispute with Xuchang Second People's Hospital, with a claim of 63.69 million RMB[11] - The arbitration request against Anhui Shangrong was withdrawn, eliminating any significant impact on the company's current or future profits[18] Impairment and Acquisitions - The company recognized a credit impairment loss of CNY 177.22 million based on the recoverable value of all debts related to Xuchang Second Hospital[14] - The transaction price for the acquisition of the entire equity of Fuping County Shangrong Hospital Investment Management Co., Ltd. is tentatively set at CNY 214.25 million, with CNY 49.5 million already paid[15] - The company plans to distribute a cash dividend of CNY 0.08 per 10 shares, totaling CNY 67.56 million (including tax) for the 2024 fiscal year[15]

Financial Performance - The company's operating revenue for Q3 2025 was CNY 133,837,885.03, representing a year-on-year increase of 3.67%[3] - The total profit for the period was CNY 12,959,155.86, a decrease of 28.08% compared to the same period last year[3] - The net profit attributable to shareholders was CNY 11,003,192.96, down 25.65% year-on-year[3] - The basic earnings per share for the period was CNY 0.12, reflecting a decline of 45.45%[4] - The net profit for the first three quarters of 2025 was CNY 50,353,118.37, a decrease of 8.99% compared to CNY 54,840,513.87 in the same period of 2024[20] - Basic and diluted earnings per share for the first three quarters of 2025 were CNY 0.63, down from CNY 0.81 in the same period of 2024, representing a decrease of 22.22%[20] Assets and Equity - The total assets at the end of the reporting period reached CNY 1,352,918,536.25, an increase of 29.66% from the end of the previous year[4] - The equity attributable to shareholders increased by 36.91% to CNY 1,176,389,569.78 compared to the end of the previous year[4] - Total assets as of September 30, 2025, were RMB 1,352,918,536.25, compared to RMB 1,043,464,748.68 at the end of 2024, indicating a growth of about 29.6%[16] - The company's equity attributable to shareholders increased to RMB 1,176,389,569.78 in 2025 from RMB 859,250,740.61 in 2024, representing a growth of about 37%[16] Cash Flow - The net cash flow from operating activities for the year-to-date was CNY 78,721,831.70, showing an increase of 19.32%[3] - The operating cash flow for the first three quarters of 2025 was CNY 78,721,831.70, an increase of 19.99% from CNY 65,973,529.16 in the first three quarters of 2024[22] - The company reported cash inflows from operating activities totaling CNY 261,752,744.98, compared to CNY 250,411,233.53 in the previous year, indicating a growth of 4.94%[22] - Total cash and cash equivalents at the end of Q3 2025 amounted to CNY 223,294,081.61, up from CNY 178,570,233.07 at the end of Q3 2024, reflecting a year-on-year increase of 25.00%[23] - Cash and cash equivalents as of September 30, 2025, were RMB 224,927,268.80, up from RMB 207,085,038.03 at the end of 2024, marking an increase of approximately 8.8%[14] Operating Costs and Expenses - Total operating costs increased to RMB 377,804,350.86 in 2025 from RMB 369,987,484.98 in 2024, reflecting a rise of about 2.2%[19] - Operating profit for the first three quarters of 2025 was RMB 60,976,764.26, down from RMB 67,207,910.69 in 2024, showing a decrease of approximately 9.2%[19] - Research and development expenses for the first three quarters of 2025 amounted to RMB 14,468,672.46, compared to RMB 13,569,312.76 in 2024, representing an increase of about 6.6%[19] Liabilities - Total liabilities decreased to RMB 176,528,966.47 in 2025 from RMB 184,214,008.07 in 2024, reflecting a decline of approximately 4.3%[16] Other Income and Gains - Non-recurring gains and losses for the period totaled CNY 2,976,551.31, down from CNY 6,015,994.42 in the previous year[7] - The company reported a net other income of RMB 46,902.65 for the first three quarters of 2025, slightly down from RMB 51,721.60 in 2024[19] - The company received tax refunds amounting to CNY 4,586,272.39, which is a significant increase from CNY 2,836,475.78 in the previous year, marking a growth of 62.00%[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 15,784[9] - The company has not reported any significant changes in shareholder participation in financing or securities lending activities during the reporting period[12] Future Outlook - The company plans to implement new accounting standards starting in 2025, which may affect the financial statements[24]

Financial Performance - The company's operating revenue for Q3 2025 was ¥19,574,760,407.17, a decrease of 5.90% compared to the same period last year[6] - Total profit for Q3 2025 increased by 52.60% to ¥420,743,681.33, driven by enhanced operations in high-value-added products[11] - Net profit attributable to shareholders for Q3 2025 was ¥354,651,340.10, reflecting a significant increase of 67.17% year-on-year[6] - The net profit after deducting non-recurring gains and losses was ¥294,544,489.28, up 43.67% compared to the previous year[6] - Basic earnings per share for Q3 2025 were ¥0.089, an increase of 75.272% year-on-year[6] - Total profit for the year-to-date period decreased by 12.77% to ¥884,456,881.59 compared to the same period last year[6] - Net profit for the first three quarters of 2025 was CNY 700.93 million, compared to CNY 786.04 million in 2024, representing a decline of 10.86%[23] - Earnings per share for the first three quarters of 2025 were CNY 0.1743, down from CNY 0.1845 in the same period of 2024[23] Cash Flow and Assets - The net cash flow from operating activities for Q3 2025 decreased by 72.82% to ¥330,110,590.30, attributed to rising aluminum prices and increased inventory[12] - The company's cash flow from operating activities for the first three quarters of 2025 showed a significant improvement, although specific figures were not provided in the available data[24] - In the first three quarters of 2025, the cash inflow from operating activities was approximately ¥65.35 billion, a slight decrease of 0.47% compared to ¥65.66 billion in the same period of 2024[25] - The net cash flow from operating activities was negative at approximately -¥1.11 billion, worsening from -¥689.15 million in the first three quarters of 2024[25] - Cash inflow from investment activities totaled approximately ¥3.02 billion, an increase of 48.3% from ¥2.04 billion in the same period of 2024[26] - The net cash flow from investment activities was negative at approximately -¥2.11 billion, compared to -¥1.10 billion in the first three quarters of 2024[26] - Cash inflow from financing activities was approximately ¥10.84 billion, up 21.0% from ¥8.95 billion in the same period of 2024[26] - The net cash flow from financing activities decreased to approximately ¥1.68 billion, down from ¥2.76 billion in the first three quarters of 2024[26] - The total cash and cash equivalents at the end of the period was approximately ¥4.83 billion, an increase from ¥4.24 billion at the end of the same period in 2024[26] - The company received approximately ¥3.01 billion from investment recoveries, significantly higher than ¥1.99 billion in the first three quarters of 2024[26] - The company paid approximately ¥912.95 million to employees, a slight increase from ¥899.62 million in the same period of 2024[25] - The company reported a cash outflow of approximately ¥884.89 million related to other operating activities, which increased from ¥436.16 million in the first three quarters of 2024[25] Shareholder Information - The total number of shareholders at the end of the reporting period is 76,015[14] - The largest shareholder, Shandong Innovation Group Co., Ltd., holds 1,122,622,650 shares, representing 29.89% of total shares[14] - The second-largest shareholder, Cui Lixin, owns 537,506,796 shares, accounting for 14.31%[14] - The company has a significant shareholder structure, with the top 10 shareholders holding a combined total of 1,800,000,000 shares, which is approximately 48.1% of total shares[15] - The company has no significant changes in the participation of major shareholders in margin financing and securities lending activities[15] Asset and Liability Overview - Total assets at the end of the reporting period were ¥28,379,710,932.30, representing an increase of 8.67% from the end of the previous year[7] - Non-current assets totaled CNY 11.11 billion in 2025, an increase of 11.97% from CNY 9.92 billion in 2024[19] - Total liabilities increased to CNY 17.08 billion in 2025, up from CNY 15.19 billion in 2024, marking a growth of 12.43%[19] - The total assets of the company reached CNY 28.38 billion in 2025, compared to CNY 26.12 billion in 2024, indicating a growth of 8.66%[19] Operational Insights - The company has focused on enhancing the management of 3C consumer electronic materials, leading to improved profit margins[11] - Research and development expenses for the first three quarters of 2025 were CNY 315.21 million, an increase of 9.66% from CNY 287.38 million in 2024[22] - The company reported an investment loss of CNY 2.87 million in 2025, a significant improvement compared to a loss of CNY 70.33 million in 2024[22] - There are no other significant reminders regarding the company's operational situation during the reporting period[16] Year-to-Date Performance - Total operating revenue for the first three quarters of 2025 was CNY 58.72 billion, a decrease of 1.38% from CNY 59.54 billion in the same period of 2024[22] - Total operating costs for the first three quarters of 2025 were CNY 57.91 billion, down from CNY 58.47 billion in 2024, reflecting a decrease of 0.95%[22]

Financial Performance - The company's operating revenue for the third quarter was ¥1,956,355,502.93, a decrease of 4.05% compared to the same period last year[5] - The net profit attributable to shareholders was ¥13,488,072.52, down 37.20% year-on-year, with a year-to-date loss of ¥61,829,221.42, representing a 196.33% decline[5] - The basic and diluted earnings per share were both ¥0.02, reflecting a decrease of 52.87% compared to the previous year[5] - Net profit for Q3 2025 was a loss of CNY 60,940,058.63, compared to a profit of CNY 65,009,643.51 in Q3 2024, indicating a significant decline[18] - The total comprehensive income attributable to the parent company was -61,829,024.65 yuan, compared to -10,321,881.13 yuan in the previous period, indicating a significant decline[19] Assets and Liabilities - The total assets at the end of the reporting period were ¥5,143,596,251.76, an increase of 9.08% from the end of the previous year[5] - The company's total assets increased to CNY 5,143,596,251.76 from CNY 4,715,579,071.58, representing a growth of 9.06%[15] - Total liabilities rose to CNY 2,895,645,242.61, up from CNY 2,409,792,792.73, marking an increase of 20.19%[15] - The company's equity attributable to shareholders decreased by 2.50% to ¥2,242,209,964.81 compared to the end of the previous year[5] - The total equity attributable to shareholders decreased to CNY 2,242,209,964.81 from CNY 2,299,758,397.29, a decline of 2.49%[15] Cash Flow - The net cash flow from operating activities was ¥147,665,898.59, a significant increase of 401.70% year-to-date[5] - The net cash flow from operating activities was 147,665,898.59 yuan, an increase from 29,433,100.61 yuan year-over-year[20] - Cash inflow from operating activities totaled 6,391,267,670.87 yuan, down from 6,730,311,257.46 yuan in the previous period[20] - Cash outflow from operating activities was 6,243,601,772.28 yuan, compared to 6,700,878,156.85 yuan last year[20] - The net cash flow from investing activities was -30,651,676.45 yuan, an improvement from -106,275,775.86 yuan in the previous period[21] Shareholder Information - Total number of common shareholders at the end of the reporting period is 85,108[10] - The largest shareholder, Huang Shaoqun, holds 9.65% of shares, amounting to 56,500,000 shares, with 40,630,000 shares pledged[10] - The top 10 shareholders include significant individual stakeholders, with Huang Shaoqun, Huang Weipeng, and Huang Weibao being brothers and actual controllers of the company[10] Operating Expenses and Income - The company reported a significant increase in operating expenses, with non-operating expenses rising by 3698.96% to ¥117,164,870.19, primarily due to performance compensation provisions[8] - Other income decreased by 36.29% to ¥11,487,046.71, attributed to a reduction in government subsidies related to daily operations[8] - Research and development expenses for Q3 2025 were CNY 62,280,525.49, down from CNY 77,769,465.16, a reduction of 20.06%[17] Performance Compensation - The estimated compensation amount for the unfulfilled performance commitment from the equity transfer is ¥115,034,400[11] - The company has recognized a provision for the estimated liability of ¥64,634,400 related to the performance compensation[11] - The company experienced a 487.62% increase in estimated liabilities, mainly due to performance compensation provisions[8] - The company is currently negotiating with relevant parties regarding the performance compensation matter[11]

Financial Performance - The company's operating revenue for Q3 2025 reached ¥144,443,687.60, representing a year-on-year increase of 216.90%[5] - The net profit attributable to shareholders was a loss of ¥28,637,870.18, an increase in loss of 59.08% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of ¥25,573,867.83, reflecting a 63.27% increase in loss year-on-year[5] - Total operating revenue for the third quarter reached ¥342,492,501.23, a significant increase from ¥153,376,811.84 in the previous year, representing a growth of approximately 123.6%[18] - The net loss for the quarter was ¥35,010,595.69, compared to a net loss of ¥54,924,506.71 in the same period last year, showing an improvement of approximately 36.3%[19] - The company's basic earnings per share for the period was -¥0.0295, a decrease of 59.08% year-on-year[5] - The basic and diluted earnings per share were both -0.0361, an improvement from -0.0556 in the previous year[19] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥1,681,960,573.99, a slight increase of 0.69% from the previous year[5] - The company's total assets increased to ¥1,681,960,573.99 from ¥1,670,461,746.64, reflecting a growth of about 0.9%[16] - Total liabilities rose to ¥871,474,350.70, compared to ¥824,964,926.66, marking an increase of approximately 5.6%[16] - The total equity attributable to shareholders decreased by 3.98% to ¥844,642,441.01 compared to the end of the previous year[5] - The total equity attributable to shareholders decreased to ¥844,642,441.01 from ¥879,674,153.13, a decline of about 4.0%[16] Cash Flow - The company's cash flow from operating activities showed a net outflow of ¥142,325,080.17, worsening by 117.56% compared to the same period last year[5] - Operating cash inflow for the current period was CNY 425,554,768.37, an increase of 36.0% from CNY 312,794,819.07 in the previous period[20] - Net cash outflow from operating activities was CNY -142,325,080.17, worsening from CNY -65,417,754.00 in the previous period[20] - Cash and cash equivalents decreased to ¥311,039,961.14 from ¥448,439,021.20, a decline of approximately 30.6%[14] - Cash and cash equivalents at the end of the period were CNY 290,120,090.37, down from CNY 482,356,931.50 in the previous period, representing a decline of 39.9%[21] - Total cash outflow from investing activities was CNY 1,286,310.58, significantly reduced from CNY 7,942,656.02 in the previous period[20] Shareholder Information - Total number of common shareholders at the end of the reporting period is 40,180[10] - The largest shareholder, Huanrui United, holds 10.87% of shares, totaling 106,651,376 shares[10] - The top 10 shareholders collectively hold 19.73% of the shares, while the top 10 unrestricted shareholders hold 12.37%[10] - The total amount of shares held by the top 10 unrestricted shareholders is 193,508,595 shares[10] - The company has not reported any changes in the participation of major shareholders in margin trading[11] - The company has not disclosed any other significant shareholder relationships or actions related to the management of shares[10] Expenses - The company experienced a 393.45% increase in selling expenses, totaling ¥201,948,484.08, driven by rapid development in short drama business[8] - Total operating costs amounted to ¥378,116,969.42, up from ¥133,300,421.47, indicating an increase of about 183.5%[18] - Research and development expenses for the quarter were ¥2,289,950.69, slightly down from ¥2,558,169.89, indicating a decrease of approximately 10.5%[18] - The company reported a significant increase in sales expenses, which reached ¥201,948,484.08, compared to ¥40,925,817.67, an increase of about 392.5%[18] Investment Income - The company recorded an investment income of ¥2,575,707.42, a turnaround from a loss of ¥2,317,740.28 in the previous year, mainly due to the disposal of an associate[8] Contracts - The company has a significant contract with iQIYI, with a total contract amount of ¥54,000,000, of which ¥22,641.51 million has been recognized as revenue[12] Audit Status - The financial report for the third quarter was not audited[22]

Financial Performance - The company's operating revenue for the third quarter was ¥893,970,433.02, a decrease of 3.87% compared to the same period last year[4] - The total profit for the quarter was ¥100,607,000.81, down 10.92% year-on-year[4] - The net profit attributable to shareholders was ¥91,659,390.12, reflecting a decline of 6.98% compared to the previous year[4] - The net profit after deducting non-recurring gains and losses was ¥79,907,530.36, a decrease of 19.85% year-on-year[4] - Basic and diluted earnings per share were both ¥0.20, down 9.09% from the same period last year[5] - Total operating revenue for the first three quarters of 2025 reached ¥2,778,269,420.94, a 20.2% increase from ¥2,311,541,742.13 in the same period of 2024[19] - Operating profit for the first three quarters of 2025 was ¥372,037,691.54, compared to ¥298,652,438.08 in 2024, reflecting a growth of 24.6%[20] - Net profit attributable to shareholders of the parent company for the first three quarters of 2025 was ¥334,343,597.54, up 32.0% from ¥253,317,192.62 in 2024[21] - Basic earnings per share for the first three quarters of 2025 increased to ¥0.74, compared to ¥0.57 in the same period of 2024[21] Cash Flow - Cash flow from operating activities increased significantly by 243.13% to ¥192,392,549.10 during the quarter[4] - Cash inflows from operating activities totaled ¥3,098,925,738.71 for the first three quarters of 2025, compared to ¥2,831,440,808.58 in 2024, showing a growth of 9.4%[22] - The net cash flow from operating activities was $19,636,595.22, a significant improvement from a negative cash flow of $39,984,610.39 in the previous period[23] - The company reported a cash flow from operating activities outflow of $3,079,289,143.49, compared to $2,871,425,418.97 previously[23] - The cash flow from operating activities generated a net cash flow of $19,636,595.22, contrasting with a negative cash flow in the prior period[23] Assets and Liabilities - The total assets at the end of the quarter reached ¥9,087,937,789.22, an increase of 14.30% compared to the end of the previous year[5] - The total current assets as of September 30, 2025, amounted to CNY 6,601,716,863.47, an increase from CNY 5,503,560,003.85 in the previous year, representing a growth of approximately 20%[15] - Total assets reached CNY 9,087,937,789.22, up from CNY 7,950,716,228.10, which is an increase of about 14.3%[16] - Total liabilities increased to ¥4,031,938,907.35 from ¥3,548,650,770.36, indicating a rise in financial obligations[17] - Total current liabilities increased to CNY 2,690,791,675.33 from CNY 2,344,436,673.11, representing a rise of approximately 14.7%[16] - Long-term borrowings rose to CNY 876,701,650.28 from CNY 725,445,660.47, indicating an increase of about 20.8%[16] - The total non-current liabilities increased to CNY 1,341,147,232.02 from CNY 1,204,214,097.25, reflecting a growth of approximately 11.4%[16] Shareholder Equity - The equity attributable to shareholders increased by 15.05% to ¥4,948,800,316.65 compared to the end of the previous year[5] - The company's total equity reached ¥5,055,998,881.87, up from ¥4,402,065,457.74, reflecting a strong capital position[17] Research and Development - Research and development expenses for the first three quarters of 2025 were ¥272,785,165.98, up from ¥235,121,271.38 in 2024, indicating a focus on innovation[20] Non-Recurring Items - The company reported a net gain from non-recurring items totaling ¥11,751,859.76 for the current period[8] Cash and Cash Equivalents - Cash and cash equivalents reached CNY 2,019,380,999.55, up from CNY 1,459,889,179.35, indicating a year-over-year increase of about 38%[14] - The total cash and cash equivalents at the end of the period reached $1,439,864,363.20, up from $659,924,014.47 at the end of the previous period[23] Other Information - The company reported no significant changes in shareholder participation in margin trading and securities lending activities[13] - There were no applicable reminders regarding the company's operational status during the reporting period[14] - The company did not apply new accounting standards starting from 2025[24]

湖南汉森制药股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 湖南汉森制药股份有限公司 2025 年第三季度报告 证券代码：002412 证券简称：汉森制药 公告编号：2025-023 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈 述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、 准确、完整。 3.第三季度财务会计报告是否经过审计 □是 否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 231,943,252.45 | 8.62% | 740,793,882.78 | 6.75% | | ...

Financial Performance - The company's operating revenue for Q3 2025 was ¥2,762,906,949.32, an increase of 3.54% compared to the same period last year[4] - The net profit attributable to shareholders for Q3 2025 was ¥201,426,091.99, representing a significant increase of 50.55% year-on-year[4] - The basic earnings per share for Q3 2025 was ¥0.1300, up 62.50% from the previous year[4] - Total operating revenue for the current period reached ¥7,956,058,652.92, an increase from ¥7,842,853,831.55 in the previous period, reflecting a growth of approximately 1.44%[20] - Total operating costs increased to ¥7,499,278,060.31 from ¥7,270,314,420.23, representing a rise of about 3.15%[20] - Net profit for the current period was ¥453,539,609.28, down from ¥565,020,843.52, indicating a decrease of approximately 19.7%[21] - Basic earnings per share decreased to ¥0.29 from ¥0.41, a decline of about 29.27%[22] - The total comprehensive income for the current period was ¥288,342,235.11, a significant drop from ¥497,810,667.66 in the previous period[21] - The company reported a tax expense of ¥40,442,421.90, up from ¥29,126,435.01, reflecting an increase of approximately 38.9%[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥18,297,028,317.92, reflecting a growth of 1.53% from the end of the previous year[5] - The company's equity attributable to shareholders increased to ¥8,909,082,452.69, a rise of 1.34% compared to the end of the previous year[5] - Current assets decreased to CNY 8,363,462,265.46 from CNY 8,663,911,933.32, reflecting a decline of approximately 3.46%[16] - The company's cash and cash equivalents decreased to CNY 2,186,943,163.73 from CNY 2,738,774,303.89, a reduction of about 20.17%[16] - Accounts receivable increased to CNY 2,432,589,862.40 from CNY 2,129,305,864.71, representing an increase of approximately 14.25%[16] - Inventory decreased to CNY 1,680,596,183.19 from CNY 1,897,871,943.30, a decline of about 11.48%[16] - Total liabilities increased to CNY 9,331,443,847.74 from CNY 9,171,120,779.99, an increase of approximately 1.75%[17] - The non-current assets increased to CNY 9,933,566,052.46 from CNY 9,356,797,580.60, reflecting an increase of approximately 6.15%[17] - Short-term borrowings decreased to CNY 1,770,209,194.41 from CNY 1,933,939,360.68, a reduction of about 8.45%[17] - The company's retained earnings increased to CNY 3,181,634,186.62 from CNY 2,944,299,709.47, an increase of approximately 8.06%[18] Cash Flow - Cash flow from operating activities for the year-to-date was ¥443,226,917.96, showing a slight increase of 1.73%[4] - Cash flow from operating activities generated a net amount of ¥443,226,917.96, slightly up from ¥435,678,029.27, showing a growth of about 1.26%[23] - Cash flow from investing activities resulted in a net outflow of ¥1,225,594,431.97, worsening from a net outflow of ¥729,624,864.17 in the previous period[24] - Cash flow from financing activities yielded a net inflow of ¥77,368,356.99, down from ¥477,004,684.57, indicating a decrease of approximately 83.85%[24] - The cash and cash equivalents at the end of the period stood at ¥1,878,847,226.32, down from ¥3,152,335,566.91, a decrease of about 40.4%[24] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 61,894[12] Financial Reporting and Standards - The third quarter financial report of Guizhou Tyre Co., Ltd. has not been audited[26] - The new accounting standards will be implemented starting from 2025, affecting the financial statements from the beginning of that year[25] - The board of directors meeting was held on October 28, 2025[26] - There are no specific performance summaries or user data provided in the documents[25][26] - No future outlook or performance guidance details are mentioned in the content[25][26] - There are no updates on new product or technology development in the provided documents[25][26] - No information regarding market expansion or mergers and acquisitions is available[25][26] - Other strategic initiatives are not discussed in the content[25][26] - The financial report does not include specific numerical data or percentages[25][26] - The documents do not provide any insights into revenue or profit figures[25][26]

Financial Performance - The company's revenue for Q3 2025 was ¥297,194,627.21, a decrease of 15.88% compared to the same period last year[5] - Net profit attributable to shareholders was ¥30,469,969.31, down 44.87% year-on-year[5] - The basic earnings per share decreased by 45.76% to ¥0.32, while diluted earnings per share fell by 57.63% to ¥0.25[5] - Total operating revenue for the current period was ¥996,893,278.22, a decrease of 1.2% from ¥1,011,516,879.41 in the previous period[24] - Net profit for the current period was ¥134,049,607.96, down 10% from ¥148,787,758.93 in the previous period[25] - The company reported a total comprehensive income of ¥134,161,654.80, compared to ¥148,785,820.41 in the previous period[26] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,919,633,653.18, a decrease of 0.96% from the end of the previous year[5] - Total assets decreased to ¥3,919,633,653.18 from ¥3,957,642,571.53, indicating a reduction in overall asset base[23] - Total liabilities decreased to ¥658,958,560.60 from ¥788,688,838.15, showing a significant reduction in financial obligations[23] - The company's equity increased to ¥3,260,675,092.58 from ¥3,168,953,733.38, indicating growth in shareholder value[23] Cash Flow - The cash flow from operating activities for the year-to-date was ¥82,765,792.46, representing an increase of 88.03%[5] - Operating cash inflow for the current period was ¥941,696,039.23, a decrease of 6.5% from ¥1,007,084,822.57 in the previous period[27] - Net cash flow from operating activities increased to ¥82,765,792.46, up 88.2% from ¥44,017,049.49 in the previous period[28] - Cash outflow from operating activities was ¥858,930,246.77, down 10.9% from ¥963,067,773.08 in the previous period[28] - Total cash and cash equivalents at the end of the period reached ¥2,064,317,829.86, a decrease from ¥2,305,071,632.72 in the previous period[28] Investments - Cash generated from investment activities was ¥1,737,479,681.65 in 2025, a significant recovery from a negative cash flow of ¥114,463,134.91 in 2024, attributed to the maturity of financial products purchased in the previous year[12] - Cash inflow from investment activities totaled ¥9,055,974,003.40, down 15.7% from ¥10,747,295,542.47 in the previous period[28] - The company received cash from investment income of ¥28,823,777.40, an increase from ¥24,277,254.47 in the previous period[28] - The company reported a cash inflow of ¥9,027,000,000.00 from the recovery of investments, down from ¥10,723,000,000.00 in the previous period[28] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,436, with no preferred shareholders having restored voting rights[14] - The top three shareholders hold a combined 40.60% of the company's shares, with Lei Huaigang holding 17.27%, Liao Yuan 13.44%, and Guan Hongfei 9.19%[14] Operational Efficiency - The company reported a significant increase in accounts receivable financing, rising by 63.52% to ¥166,192,731.40 due to an increase in high-rated bank acceptance bills[9] - Accounts receivable decreased to ¥377,218,988.81 from ¥415,750,034.73, indicating improved collection efficiency[21] - Inventory levels decreased from ¥342,493,812.92 to ¥276,748,130.22, suggesting better inventory management practices[21] - Operating cash flow for the first nine months of 2025 reached ¥82,765,792.46, an increase of 88.03% compared to ¥44,017,049.49 in the same period of 2024, primarily due to improved sales collection management[12] Research and Development - Research and development expenses increased to ¥98,430,213.85, up from ¥85,542,858.38, reflecting a focus on innovation[24] Stock and Incentives - The company approved the cancellation of 760,000 restricted stock grants due to unmet vesting conditions for 32 incentive recipients[17] - The stock grant price for the 2024 restricted stock incentive plan was adjusted from ¥38.50 to ¥38.15 per share following the completion of the annual equity distribution plan[18]

Financial Performance - The company's revenue for Q3 2025 reached ¥1,204,152,120.07, representing a 9.90% increase year-over-year[5] - Net profit attributable to shareholders increased by 50.14% to ¥154,595,984.20 for the quarter[5] - The net profit excluding non-recurring gains and losses rose by 41.97% to ¥142,880,736.07[5] - Total operating revenue for the current period reached ¥3,385,378,103.89, an increase of 5.73% compared to ¥3,201,188,250.42 in the previous period[16] - Net profit for the current period was ¥340,126,596.11, representing a 30.03% increase from ¥261,505,974.42 in the previous period[17] - Basic and diluted earnings per share were both ¥0.4093, compared to ¥0.3137 in the prior period, reflecting a significant improvement[18] Assets and Liabilities - Total assets at the end of the reporting period were ¥6,550,292,089.22, a 6.23% increase from the previous year[5] - Total assets increased to ¥6,550,292,089.22, up from ¥6,166,022,812.07, indicating a growth of 6.22%[15] - Total liabilities rose to ¥2,528,205,538.63, compared to ¥1,960,902,983.88, marking an increase of 28.94%[15] - Non-current assets totaled ¥3,124,705,343.02, an increase from ¥2,772,538,683.67, reflecting a growth of 12.70%[14] Cash Flow - Cash flow from operating activities for the year-to-date increased by 31.36% to ¥543,129,044.29[5] - Operating cash flow for the period was CNY 543,129,044.29, an increase of 31.3% compared to CNY 413,479,030.01 in the previous period[19] - Total cash inflow from investment activities was CNY 2,641,322,425.76, a decrease of 2.8% from CNY 2,717,733,631.02 in the prior period[20] - Cash outflow for investments increased significantly to CNY 4,125,084,250.17, up from CNY 2,997,075,057.07, resulting in a net cash flow from investment activities of -CNY 1,483,761,824.41[20] - Cash inflow from financing activities totaled CNY 1,076,752,232.50, compared to CNY 874,000,000.00 in the previous period[20] - Net cash flow from financing activities was CNY 10,778,020.05, a recovery from -CNY 909,290,015.55 in the prior period[20] - The ending balance of cash and cash equivalents was CNY 200,443,234.25, down from CNY 1,299,598,679.45 at the end of the previous period[20] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 25,005[11] - The number of shares held by the top 10 unrestricted shareholders includes 137,500,000 shares held by Weijia International Enterprises Limited, representing a substantial ownership stake[12] - The largest shareholder, Nantong Luolai Life Technology Development Group Co., Ltd., holds 128,202,869 shares, accounting for 15.37% of the company[12] - The company has no participation in margin financing or securities lending activities among the top 10 shareholders[12] Investment and Assets Management - The company reported a significant increase of 210.03% in notes receivable, totaling ¥4,956,300[9] - Investment income surged by 172% compared to the previous year, attributed to increased maturity amounts of financial products[9] - The company experienced a 431.16% decrease in cash flow from investing activities due to increased investment expenditures[9] - Total current assets increased slightly to ¥3,425,586,746.20 from ¥3,393,484,128.40, reflecting stable asset management[13] - Inventory levels decreased to ¥1,038,023,046.33 from ¥1,086,618,634.27, suggesting improved inventory turnover[13] - The company reported a significant increase in other debt investments, rising to ¥560,567,869.50 from ¥170,832,291.66, indicating a strategic shift in investment focus[13] - The company has a total of ¥207,000,000.00 in trading financial assets, down from ¥407,084,799.94, reflecting a strategic reduction in trading activities[13] - The company’s total non-current assets include long-term equity investments of ¥1,606,564.38, remaining stable compared to previous periods[13] Research and Development - The company reported a decrease in research and development expenses to ¥84,366,655.91 from ¥97,587,408.77, a reduction of 13.56%[16] Audit Status - The company’s financial report for Q3 was not audited[21]